Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Adesis

Adesis?uq=w9if130k
1991 FOUNDED
M&A STATUS
41-50 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Owner and operator of a contract research organization. The company specializes in organic synthesis and also synthesis of milligrams to kilogram quantities while supporting the pharmaceutical and bio pharmaceutical industry, bio materials and catalysts industry.

Formerly Known As
CB Research and Development
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Commercial Services
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • 27 McCullough Drive
  • New Castle, DE 19720
  • United States

+1 (302) 000-0000

Adesis Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Adesis‘s full profile, request access.

Request full access to PitchBook

Adesis Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Adesis‘s full profile, request access.

Request full access to PitchBook

Adesis Executive Team (4)

Name Title Board
Seat
Contact
Info
Ving Lee Ph.D Chief Executive Officer & Chief Scientific Officer
Andrew Cottone Ph.D President & Vice President, Chemistry
John Chiarello Ph.D Director of Chemistry

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »